Business
PharmAust Receives $672,250 R&D Tax Incentive Refund
PharmAust Receives $672,250 R&D Tax Incentive Refund
About this update from Neurizon Therapeutics Limited
[{"type":"text","content":"Neurizon Therapeutics Limited has released a press release. View Attachment","length":258,"tagName":"div"}]